Aug 27, 2026 04:05PM
Aug 10, 2026 04:05PM
Jul 15, 2026 04:05PM
Jul 14, 2026 04:05PM
Mar 10, 2026 05:05PM
Sep 2, 2025 01:30AM
Jun 15, 2025 04:00AM QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs)
Mar 6, 2025 01:00AM
Feb 5, 2025 04:05PM
Jan 9, 2025 04:05PM
Nov 28, 2024 06:00AM
Jul 31, 2024 04:06PM
May 30, 2024 05:55PM
Aug 7, 2023 04:05PM QIAGEN receives FDA approval for companion diagnostic to Blueprint Medicines’ AYVAKIT® (avapritinib) in gastrointestinal stromal tumors
Mar 9, 2023 01:30AM
Feb 14, 2023 04:05PM
Jan 5, 2023 04:05PM
Jan 5, 2023 04:05PM
Dec 13, 2022 05:00AM
Sep 14, 2022 04:05PM
Sep 14, 2022 04:01PM Neuron23 and QIAGEN Announce Collaboration to Develop the First Next-Generation Sequencing Companion Diagnostic for Novel Parkinson's Disease Drug
Jul 27, 2022 01:40AM
Jan 6, 2022 04:05PM
Dec 9, 2021 09:30AM
Dec 9, 2021 01:30AM
Nov 29, 2021 01:10AM
Nov 2, 2021 04:05PM
Aug 9, 2021 04:05PM QIAGEN and OncXerna Therapeutics Sign Licensing and Master Companion Diagnostic Agreements
Aug 6, 2021 01:19PM
Aug 6, 2021 01:15PM
Jul 8, 2021 04:22PM
Jul 8, 2021 04:22PM
Jul 1, 2021 05:04PM
Jul 1, 2021 05:03PM
Jul 1, 2021 01:59AM QIAGEN Forms Strategic Alliance With Sysmex Corporation for Global Cancer Companion Diagnostics Development and Commercialization Using NGS and Plasma-Safe-SeqS Technology
May 28, 2021 01:46PM
May 28, 2021 01:45PM
May 25, 2021 04:19PM
May 25, 2021 04:05PM
May 12, 2021 04:07PM
May 12, 2021 04:05PM
Apr 20, 2021 04:15PM Qiagen (QGEN) Launches artus Prep&Amp as CE-Marked SARS-CoV-2 Test Offering up to Threefold Increase in Daily Lab Testing Capacity
Apr 20, 2021 04:05PM
Mar 29, 2021 06:35AM
Mar 29, 2021 02:00AM
Jan 20, 2021 04:11PM
Jan 20, 2021 04:08PM
Nov 18, 2020 04:05PM
Nov 16, 2020 04:05PM QIAGEN Launches NeuMoDx Multiplex Test to Complete Range of SARS-CoV-2 Testing Solutions in Europe and Other Markets
Nov 11, 2020 05:34PM

330,769 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All